ALOX5 rs4986832: Understanding This Genetic Variant
The rs4986832 variant is a single nucleotide polymorphism located within the ALOX5 gene, which encodes the enzyme 5-lipoxygenase. Researchers have investigated this variant for its potential influence on inflammatory pathways, cardiovascular health, and individual responses to certain medications.
What each genotype means
Typical ALOX5 expression
This genotype represents the most common form of the ALOX5 gene variant. Research suggests that individuals with this profile may have a different response to leukotriene-inhibitor medications, such as montelukast, compared to those with variant alleles. Please discuss any medication-related concerns or treatment responses with your clinician or pharmacist.
This is the most common genotype observed in most studied populations.
Potential altered drug response
Carrying one copy of the variant allele may influence how your body processes leukotrienes or responds to specific anti-inflammatory therapies. Studies have investigated this variant's role in cardiovascular health and asthma treatment efficacy, though results can vary significantly between individuals. Always consult your healthcare provider regarding the management of inflammatory conditions or medication choices.
This genotype is found at varying frequencies across different global populations.
Variant ALOX5 expression
Individuals with this genotype carry two copies of the variant allele, which has been associated in some studies with altered ALOX5 promoter activity and potential differences in cardiovascular disease risk markers. Research indicates that this genotype may be linked to a different clinical response to leukotriene-inhibitor medications. You should discuss your specific health history and any medication responses with your doctor.
This genotype is less common than the wild-type CC genotype and its prevalence varies by ancestry.
What is rs4986832?
The rs4986832 variant is a specific genetic change, or single nucleotide polymorphism (SNP), found within the ALOX5 gene. This gene is located on chromosome 10 in humans. In the context of genomics, a SNP represents a variation at a single position in the DNA sequence among individuals. The ALOX5 gene provides instructions for making the enzyme arachidonate 5-lipoxygenase. This enzyme is a critical component of the inflammatory response, as it is responsible for the initial steps in the biosynthesis of leukotrienes. Leukotrienes are signaling molecules that play significant roles in immune function and inflammation. Because of its central role in these pathways, variations in the ALOX5 gene, including rs4986832, have been the subject of numerous studies aiming to understand how genetic differences might contribute to variability in human health, particularly in conditions where inflammation is a key factor.
The Role of the ALOX5 Gene
The ALOX5 gene encodes the 5-lipoxygenase enzyme, which is primarily expressed in leukocytes, such as neutrophils, eosinophils, and monocytes. This enzyme catalyzes the conversion of arachidonic acid into 5-hydroperoxyeicosatetraenoic acid (5-HPETE), which is subsequently converted into leukotrienes. Leukotrienes are potent mediators of inflammation and are involved in the pathophysiology of various respiratory and cardiovascular conditions. By regulating the production of these lipid mediators, the ALOX5 gene influences how the body responds to injury, infection, and chronic inflammatory stimuli. Because the activity of this enzyme can directly impact the levels of inflammatory markers in the blood, scientists have long hypothesized that genetic variations affecting the expression or function of ALOX5 could lead to differences in disease susceptibility or the severity of inflammatory responses across different individuals.
Research Associations and Evidence
Research into rs4986832 has yielded mixed results, reflecting the complexity of genetic associations. Some early studies suggested that variants in the ALOX5 pathway might be linked to cardiovascular disease risk or differences in how patients respond to anti-inflammatory medications like montelukast. For instance, specific genotypes have been explored for their potential to influence peak expiratory flow improvements in asthma patients. However, other large-scale studies, such as those conducted within the Multi-Ethnic Study of Atherosclerosis (MESA), have found no significant association between ALOX5 variants and clinical cardiovascular events or subclinical atherosclerosis. The evidence for this variant is considered moderate and often context-dependent, meaning that findings in one population or clinical setting may not be replicated in others. It is important to recognize that genetic associations are statistical in nature and do not imply a direct cause-and-effect relationship for any individual.
What You Can Do With This Information
Understanding your genetic profile can be an educational experience, but it is essential to interpret this information within the proper context. Genetic variants like rs4986832 are only one piece of a much larger puzzle that includes lifestyle, environment, and other genetic factors. You cannot use this information to diagnose yourself with a condition or to predict your future health outcomes with certainty. If you are interested in how your genetics might influence your response to specific medications, such as those used for asthma or inflammation, you should discuss this with your clinician or pharmacist. They are the best resources to help you understand how your genetic data might—or might not—be relevant to your personalized treatment plan. Always rely on professional medical advice rather than direct-to-consumer genetic reports when making decisions about your health or medical care.
How common is this variant?
The frequency of the rs4986832 alleles varies significantly across different global populations and ancestral groups. Because of this variability, the prevalence of specific genotypes is not uniform worldwide.
Frequently asked questions
Is rs4986832 a cause of heart disease?
No, rs4986832 is not considered a direct cause of heart disease. While some research has investigated its potential association with cardiovascular markers, large studies have often failed to find a significant link between this variant and clinical heart disease events.
Can I use this SNP to predict my asthma medication response?
While some studies have explored the role of ALOX5 variants in medication response, the evidence is not definitive. You should never change your medication regimen based on genetic data; always consult your doctor or pharmacist regarding your treatment.
Why do different studies report different results for this variant?
Genetic studies often show different results due to differences in study design, the ancestry of the participants, and the influence of environmental factors. This is common in complex traits where many genes and lifestyle factors interact.
Should I get tested for ALOX5 variants?
There is currently no standard clinical recommendation to test for the rs4986832 variant for general health purposes. Genetic testing should be discussed with a healthcare provider to determine if it is relevant to your specific medical situation.
Sources & further reading
Educational information only, last refreshed 10/27/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs4986832?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29